Nifty

:

11504.95

Sensex

:

38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Login

Nifty
Sensex

:
:

11504.95
38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

Rating :

64/99

BSE: 532612 | NSE: INDOCO

Watchlist

NSE BSE

269.85

18-Sep-2020

Open
High
Low
Previous Close

283.00
290.00
265.00
281.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

285653
790.00
296.00
132.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,487.14
65.87
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,747.19
0.11%
3.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.28
2.47
-3.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.64
-14.27
-13.08

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

35.03
43.67
65.14

P:BV (Average)

8 Years
5 Years
3 Years

3.01
3.01
3.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.56
17.20
18.21

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 275.86 252.67 9.18% 272.02 252.02 7.94% 289.34 262.56 10.20% 291.97 235.63 23.91%
Expenses 227.00 229.92 -1.27% 238.68 223.47 6.81% 254.23 237.78 6.92% 259.83 223.82 16.09%
EBITDA 48.86 22.75 114.77% 33.34 28.55 16.78% 35.11 24.78 41.69% 32.14 11.81 172.14%
EBIDTM 17.71% 9.00% -0.29% 11.33% 12.13% 9.44% 11.01% 5.01%
Other Income 0.26 0.64 -59.38% 0.49 4.94 -90.08% 0.72 0.57 26.32% 0.58 0.33 75.76%
Interest 5.75 6.12 -6.05% 7.83 4.63 69.11% 6.93 3.72 86.29% 5.37 5.01 7.19%
Depreciation 19.13 16.99 12.60% 18.20 19.46 -6.47% 17.58 17.73 -0.85% 18.04 17.65 2.21%
PBT 24.24 0.28 8,557.14% 7.80 9.40 -17.02% 11.32 3.90 190.26% 9.31 -10.52 -
Tax 7.01 -1.90 - 2.40 -2.23 - 1.98 -1.44 - 1.98 -2.73 -
PAT 17.23 2.18 690.37% 5.40 11.63 -53.57% 9.34 5.34 74.91% 7.33 -7.79 -
PATM 6.25% 0.86% 2.87% 4.61% 3.23% 2.03% 2.51% -3.31%
EPS 1.87 0.24 679.17% 0.59 1.26 -53.17% 1.01 0.58 74.14% 0.80 -0.84 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 275.86 252.68 9.17% 271.99 0.00 0 289.35 262.64 10.17% 292.57 235.97 23.99%
Expenses 227.21 230.26 -1.32% 238.70 0.00 0 254.48 237.92 6.96% 259.94 223.84 16.13%
EBITDA 48.65 22.42 116.99% 33.29 0.00 0 34.87 24.72 41.06% 32.63 12.13 169.00%
EBIDTM 17.64% 8.87% 14.01% 0.00% 12.05% 9.41% 11.15% 5.14%
Other Income 0.26 0.64 -59.38% 0.50 0.00 0 0.72 0.56 28.57% 0.58 0.34 70.59%
Interest 5.75 6.12 -6.05% 7.83 0.00 0 6.93 3.73 85.79% 5.37 5.01 7.19%
Depreciation 19.13 16.99 12.60% 18.20 0.00 0 17.59 17.72 -0.73% 18.04 17.64 2.27%
PBT 24.03 -0.06 - 7.76 0.00 0 11.07 3.83 189.03% 9.80 -10.18 -
Tax 6.99 -1.91 - 2.40 0.00 0 1.97 -1.44 - 1.99 -2.73 -
PAT 17.04 1.85 821.08% 5.36 0.00 0 9.10 5.27 72.68% 7.81 -7.45 -
PATM 6.18% 0.73% 7.11% 0.00% 3.15% 2.01% 2.67% -3.16%
EPS 1.85 0.20 825.00% 0.58 0.00 0 0.99 0.57 73.68% 0.85 -0.81 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 1,129.19 967.73 1,038.21 1,072.06 1,004.76 854.00 727.71 630.39 568.77 481.07 398.28 Net Sales Growth 12.59% -6.79% -3.16% 6.70% 17.65% 17.35% 15.44% 10.83% 18.23% 20.79% Cost Of Goods Sold 753.14 320.17 346.03 359.60 347.97 298.45 269.17 262.57 244.98 208.56 173.31 Gross Profit 376.05 647.56 692.18 712.46 656.79 555.55 458.55 367.81 323.79 272.51 224.97 GP Margin 33.30% 66.92% 66.67% 66.46% 65.37% 65.05% 63.01% 58.35% 56.93% 56.65% 56.49% Total Expenditure 979.74 891.03 906.73 917.40 836.83 688.80 609.86 537.93 484.19 413.39 344.62 Power & Fuel Cost - 28.49 26.62 23.12 21.72 20.39 18.26 16.37 18.48 17.29 13.95 % Of Sales - 2.94% 2.56% 2.16% 2.16% 2.39% 2.51% 2.60% 3.25% 3.59% 3.50% Employee Cost - 231.26 220.34 216.05 181.41 139.64 129.05 107.74 81.88 67.27 53.26 % Of Sales - 23.90% 21.22% 20.15% 18.06% 16.35% 17.73% 17.09% 14.40% 13.98% 13.37% Manufacturing Exp. - 106.86 101.47 96.11 84.80 52.60 39.66 34.30 30.98 27.12 25.60 % Of Sales - 11.04% 9.77% 8.96% 8.44% 6.16% 5.45% 5.44% 5.45% 5.64% 6.43% General & Admin Exp. - 110.90 109.03 116.21 102.31 90.21 83.30 66.58 57.12 51.09 45.06 % Of Sales - 11.46% 10.50% 10.84% 10.18% 10.56% 11.45% 10.56% 10.04% 10.62% 11.31% Selling & Distn. Exp. - 62.75 70.53 73.22 55.89 50.99 47.82 33.02 35.30 29.60 20.29 % Of Sales - 6.48% 6.79% 6.83% 5.56% 5.97% 6.57% 5.24% 6.21% 6.15% 5.09% Miscellaneous Exp. - 30.58 32.70 33.09 42.73 36.51 22.60 17.36 15.45 12.45 20.29 % Of Sales - 3.16% 3.15% 3.09% 4.25% 4.28% 3.11% 2.75% 2.72% 2.59% 3.30% EBITDA 149.45 76.70 131.48 154.66 167.93 165.20 117.85 92.46 84.58 67.68 53.66 EBITDA Margin 13.24% 7.93% 12.66% 14.43% 16.71% 19.34% 16.19% 14.67% 14.87% 14.07% 13.47% Other Income 2.05 6.15 8.15 6.10 4.14 1.74 3.96 1.50 2.26 5.89 4.47 Interest 25.88 20.54 23.51 6.16 12.15 10.34 18.80 21.87 16.33 3.53 2.91 Depreciation 72.95 71.56 67.71 63.27 60.63 47.11 30.91 23.72 19.25 13.45 12.10 PBT 52.67 -9.24 48.43 91.34 99.29 109.48 72.11 48.37 51.27 56.58 43.13 Tax 13.37 -6.40 7.23 13.88 17.00 26.67 14.21 5.71 4.92 5.47 1.04 Tax Rate 25.38% 69.26% 14.93% 15.20% 17.12% 24.36% 19.71% 11.80% 9.60% 9.67% 2.41% PAT 39.30 -2.84 41.20 77.46 82.29 82.81 57.90 42.66 46.34 51.12 42.09 PAT before Minority Interest 39.30 -2.84 41.20 77.46 82.29 82.81 57.90 42.66 46.34 51.12 42.09 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.48% -0.29% 3.97% 7.23% 8.19% 9.70% 7.96% 6.77% 8.15% 10.63% 10.57% PAT Growth 245.95% - -46.81% -5.87% -0.63% 43.02% 35.72% -7.94% -9.35% 21.45% EPS 4.26 -0.31 4.47 8.40 8.93 8.98 6.28 4.63 5.03 5.54 4.57

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Net Sales - 968.45 1,041.94 1,074.77 1,008.12 857.32 732.61 630.79 243.43 194.15 Net Sales Growth - -7.05% -3.05% 6.61% 17.59% 17.02% 16.14% 159.13% 25.38% Cost Of Goods Sold - 320.25 347.83 361.27 350.01 300.44 271.98 262.57 104.32 81.04 Gross Profit - 648.19 694.11 713.49 658.12 556.87 460.63 368.22 139.10 113.10 GP Margin - 66.93% 66.62% 66.39% 65.28% 64.95% 62.88% 58.37% 57.14% 58.25% Total Expenditure - 891.80 910.37 920.27 840.17 691.81 614.44 538.15 198.37 154.21 Power & Fuel Cost - 28.49 26.62 23.12 21.72 20.39 18.26 16.37 7.32 4.17 % Of Sales - 2.94% 2.55% 2.15% 2.15% 2.38% 2.49% 2.60% 3.01% 2.15% Employee Cost - 231.66 220.91 216.67 181.87 140.04 129.54 107.87 25.71 20.09 % Of Sales - 23.92% 21.20% 20.16% 18.04% 16.33% 17.68% 17.10% 10.56% 10.35% Manufacturing Exp. - 107.07 101.94 96.38 85.18 52.92 40.58 34.30 14.25 9.22 % Of Sales - 11.06% 9.78% 8.97% 8.45% 6.17% 5.54% 5.44% 5.85% 4.75% General & Admin Exp. - 110.92 110.04 116.40 102.56 90.39 83.49 66.64 25.10 22.56 % Of Sales - 11.45% 10.56% 10.83% 10.17% 10.54% 11.40% 10.56% 10.31% 11.62% Selling & Distn. Exp. - 62.75 70.53 73.22 55.89 51.00 47.83 33.02 15.97 12.76 % Of Sales - 6.48% 6.77% 6.81% 5.54% 5.95% 6.53% 5.23% 6.56% 6.57% Miscellaneous Exp. - 30.66 32.49 33.20 42.94 36.63 22.75 17.38 5.70 4.37 % Of Sales - 3.17% 3.12% 3.09% 4.26% 4.27% 3.11% 2.76% 2.34% 2.25% EBITDA - 76.65 131.57 154.50 167.95 165.51 118.17 92.64 45.06 39.94 EBITDA Margin - 7.91% 12.63% 14.38% 16.66% 19.31% 16.13% 14.69% 18.51% 20.57% Other Income - 6.15 8.05 5.93 4.03 1.71 3.97 1.50 10.02 4.81 Interest - 20.54 23.51 6.21 12.39 10.58 18.92 21.87 5.79 3.75 Depreciation - 71.57 67.71 63.28 60.66 47.09 30.90 23.72 6.32 4.34 PBT - -9.31 48.40 90.94 98.93 109.55 72.32 48.55 42.96 36.65 Tax - -6.41 7.24 13.87 16.99 26.73 14.28 5.79 11.47 11.61 Tax Rate - 68.85% 14.96% 15.25% 17.17% 24.40% 19.75% 11.93% 26.70% 31.68% PAT - -2.90 41.16 77.06 81.94 82.81 57.98 42.72 31.49 25.04 PAT before Minority Interest - -2.90 41.16 77.06 81.94 82.81 58.03 42.76 31.49 25.04 Minority Interest - 0.00 0.00 0.00 0.00 0.00 -0.05 -0.04 0.00 0.00 PAT Margin - -0.30% 3.95% 7.17% 8.13% 9.66% 7.91% 6.77% 12.94% 12.90% PAT Growth - - -46.59% -5.96% -1.05% 42.83% 35.72% 35.66% 25.76% EPS - -0.31 4.46 8.36 8.89 8.98 6.29 4.63 3.42 2.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 661.08 675.56 651.88 576.45 518.38 456.97 414.04 379.95 350.20 310.51 Share Capital 18.43 18.43 18.43 18.43 18.43 18.43 18.43 12.29 12.29 12.29 Total Reserves 642.65 657.13 633.45 558.02 499.95 438.54 395.61 367.66 337.91 298.22 Non-Current Liabilities 116.34 125.27 146.97 66.33 64.58 69.84 78.22 89.33 92.10 90.29 Secured Loans 128.66 123.28 132.31 34.24 9.42 7.20 21.41 46.24 54.05 56.96 Unsecured Loans 0.00 0.00 0.00 3.64 3.44 6.59 5.97 0.00 0.00 9.08 Long Term Provisions 15.91 23.74 30.87 40.72 15.03 16.34 6.82 4.56 3.50 0.00 Current Liabilities 445.33 416.89 390.37 301.77 258.58 199.28 197.08 182.27 120.92 78.26 Trade Payables 170.70 149.44 164.17 131.01 118.63 69.14 68.09 76.45 46.61 41.55 Other Current Liabilities 117.02 119.32 72.07 57.30 40.88 53.88 51.32 50.03 37.46 22.10 Short Term Borrowings 113.39 109.93 118.36 86.47 73.06 56.60 62.84 41.46 22.77 0.00 Short Term Provisions 44.21 38.19 35.77 26.99 26.02 19.66 14.84 14.33 14.07 14.61 Total Liabilities 1,222.75 1,217.72 1,189.22 944.55 841.54 726.09 689.34 651.55 563.22 479.06 Net Block 467.52 488.73 439.75 373.26 339.41 325.28 321.43 301.62 212.62 197.38 Gross Block 934.50 884.96 769.49 641.58 547.28 481.41 446.94 403.58 295.88 267.59 Accumulated Depreciation 466.98 396.23 329.74 268.32 207.87 156.14 125.51 101.96 83.27 70.21 Non Current Assets 686.25 680.57 619.04 483.08 460.11 424.88 416.45 389.55 337.40 227.93 Capital Work in Progress 185.43 135.56 90.63 54.80 62.71 44.12 37.78 32.61 52.70 30.53 Non Current Investment 2.44 2.61 2.82 2.61 0.64 0.45 0.40 0.12 0.02 0.02 Long Term Loans & Adv. 21.75 33.58 66.34 48.02 57.13 54.80 56.52 54.90 68.61 0.00 Other Non Current Assets 9.11 20.09 19.51 4.39 0.21 0.25 0.31 0.30 3.45 0.00 Current Assets 536.50 537.15 570.18 461.46 381.43 301.20 272.90 262.01 225.82 251.08 Current Investments 0.00 0.00 0.00 15.68 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 183.37 193.23 185.04 164.47 146.20 108.26 92.76 101.89 80.42 69.12 Sundry Debtors 194.47 207.83 215.73 187.72 153.64 137.25 127.08 113.71 91.79 90.71 Cash & Bank 36.18 11.81 62.40 12.44 15.28 13.14 11.81 10.48 23.80 37.55 Other Current Assets 122.48 6.45 17.63 8.65 66.31 42.55 41.25 35.93 29.81 53.70 Short Term Loans & Adv. 106.94 117.83 89.38 72.50 61.98 38.41 35.29 33.41 27.50 53.70 Net Current Assets 91.17 120.27 179.81 159.70 122.85 101.92 75.82 79.74 104.90 172.81 Total Assets 1,222.75 1,217.72 1,189.22 944.54 841.54 726.08 689.35 651.56 563.22 479.06

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Shareholder's Funds 660.62 674.98 651.34 576.52 518.80 457.15 414.17 198.38 175.31 Share Capital 18.43 18.43 18.43 18.43 18.43 18.43 18.43 11.82 11.82 Total Reserves 642.19 656.55 632.91 558.08 500.37 438.72 395.74 186.56 163.49 Non-Current Liabilities 116.42 125.34 147.04 66.28 64.65 69.87 78.22 53.79 59.52 Secured Loans 128.66 123.28 132.31 34.24 9.42 7.20 21.41 26.45 30.37 Unsecured Loans 0.00 0.00 0.00 3.64 3.44 6.59 5.97 9.81 19.39 Long Term Provisions 15.95 23.77 30.91 40.63 15.04 16.36 6.82 0.00 0.00 Current Liabilities 445.50 417.36 390.39 302.95 262.12 202.15 199.28 58.53 50.09 Trade Payables 170.72 149.55 164.03 131.31 119.86 70.66 68.26 41.06 34.19 Other Current Liabilities 117.13 119.66 72.16 57.38 40.97 53.98 51.34 7.40 7.32 Short Term Borrowings 113.39 109.93 118.36 87.23 75.38 57.96 64.84 0.00 0.00 Short Term Provisions 44.26 38.22 35.84 27.03 25.92 19.54 14.84 10.07 8.58 Total Liabilities 1,222.54 1,217.68 1,188.77 945.75 845.57 729.42 691.87 310.70 284.92 Net Block 467.65 488.86 439.89 373.64 339.80 325.43 321.55 138.99 83.28 Gross Block 934.65 885.11 769.65 641.95 547.64 481.56 447.06 165.56 103.94 Accumulated Depreciation 467.00 396.25 329.75 268.32 207.84 156.13 125.51 26.57 20.65 Non Current Assets 684.49 678.73 616.72 481.20 460.22 424.85 416.36 143.54 96.15 Capital Work in Progress 185.43 135.56 90.63 54.80 62.71 44.12 37.78 4.55 12.86 Non Current Investment 0.02 0.02 0.02 0.02 0.17 0.17 0.12 0.00 0.00 Long Term Loans & Adv. 22.01 33.92 66.46 48.15 57.31 54.88 56.59 0.00 0.00 Other Non Current Assets 9.38 20.36 19.72 4.60 0.22 0.25 0.31 0.00 0.00 Current Assets 538.05 538.96 572.05 464.55 385.36 304.56 275.51 166.28 187.37 Current Investments 0.00 0.00 0.00 15.68 0.00 0.00 0.00 6.33 40.07 Inventories 183.45 193.38 186.94 166.69 149.12 110.22 93.18 35.60 30.11 Sundry Debtors 195.84 209.51 215.68 188.83 155.38 138.13 127.08 83.41 74.07 Cash & Bank 36.26 11.90 62.59 12.63 15.40 13.39 13.99 25.20 28.58 Other Current Assets 122.51 6.46 17.64 8.66 65.46 42.83 41.25 15.73 14.54 Short Term Loans & Adv. 106.96 117.71 89.21 72.06 61.13 38.68 35.29 15.73 14.54 Net Current Assets 92.55 121.60 181.66 161.60 123.23 102.41 76.23 107.75 137.28 Total Assets 1,222.54 1,217.69 1,188.77 945.75 845.58 729.41 691.87 310.70 284.92

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 132.13 122.76 87.81 112.31 109.91 99.94 68.86 69.07 37.81 47.84 PBT -9.24 48.43 91.34 99.29 109.48 72.11 48.37 51.27 56.58 43.13 Adjustment 89.34 97.82 64.31 78.78 64.96 50.27 47.14 33.07 10.99 11.66 Changes in Working Capital 55.66 -13.59 -44.07 -38.46 -39.86 -7.84 -18.32 -5.27 -17.92 -0.61 Cash after chg. in Working capital 135.75 132.65 111.57 139.61 134.58 114.54 77.19 79.07 49.65 54.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.62 -9.89 -23.77 -27.31 -24.68 -14.60 -8.33 -10.00 -11.84 -6.34 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -103.76 -135.43 -170.54 -112.62 -88.39 -40.93 -42.89 -63.86 -76.91 -46.71 Net Fixed Assets -99.41 -160.40 -163.74 -86.39 -84.46 -40.81 -48.53 -87.61 -50.46 -47.52 Net Investments 0.17 0.21 15.47 -17.65 -0.19 -0.05 -0.28 -0.10 0.00 0.00 Others -4.52 24.76 -22.27 -8.58 -3.74 -0.07 5.92 23.85 -26.45 0.81 Cash from Financing Activity -16.14 -38.77 132.40 0.17 -20.63 -58.23 -26.41 -17.44 24.40 7.39 Net Cash Inflow / Outflow 12.23 -51.44 49.67 -0.15 0.89 0.78 -0.44 -12.23 -14.70 8.52 Opening Cash & Equivalents 8.48 59.92 10.25 10.40 9.52 8.74 9.18 21.41 36.11 29.02 Closing Cash & Equivalent 20.72 8.48 59.92 10.25 10.40 9.52 8.74 9.18 21.41 37.55

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Cash From Operating Activity 132.11 122.72 88.64 113.34 109.04 98.81 68.69 36.99 6.11 PBT -9.31 48.40 90.94 100.58 109.55 72.32 48.55 42.96 36.65 Adjustment 89.35 97.67 64.60 76.29 65.21 50.38 47.14 6.77 4.11 Changes in Working Capital 55.62 -13.23 -43.25 -36.12 -41.01 -9.16 -18.57 -5.99 -26.02 Cash after chg. in Working capital 135.66 132.83 112.29 140.75 133.75 113.53 77.12 43.73 14.74 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.55 -10.12 -23.65 -27.41 -24.71 -14.72 -8.43 -6.74 -8.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -103.76 -135.43 -170.55 -111.96 -88.41 -40.98 -42.61 -15.75 -89.60 Net Fixed Assets -99.41 -160.40 -163.74 -86.39 -84.46 -40.81 -349.01 -29.62 Net Investments 0.17 0.21 15.47 -17.65 -0.19 -0.05 11.09 33.74 Others -4.52 24.76 -22.28 -7.92 -3.76 -0.12 295.31 -19.87 Cash from Financing Activity -16.14 -38.77 131.57 -1.48 -19.92 -58.98 -24.41 -24.61 94.50 Net Cash Inflow / Outflow 12.22 -51.48 49.66 -0.11 0.70 -1.15 1.67 -3.38 11.01 Opening Cash & Equivalents 8.58 60.06 10.40 10.47 9.77 10.92 9.25 28.58 17.57 Closing Cash & Equivalent 20.80 8.58 60.06 10.36 10.47 9.77 10.92 25.20 28.58

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 71.74 73.31 70.74 62.55 56.25 49.59 44.93 41.23 38.00 33.69 ROA -0.23% 3.42% 7.26% 9.21% 10.57% 8.18% 6.36% 7.63% 9.81% 9.41% ROE -0.43% 6.21% 12.61% 15.03% 16.98% 13.29% 10.75% 12.69% 15.47% 14.30% ROCE 1.18% 7.61% 11.84% 16.78% 20.66% 16.83% 13.68% 14.33% 14.55% 12.96% Fixed Asset Turnover 1.06 1.26 1.55 1.69 1.68 1.60 1.51 1.65 1.73 1.60 Receivable days 75.87 74.21 67.30 62.00 61.36 65.15 68.49 65.09 68.51 86.66 Inventory Days 71.02 66.28 58.30 56.43 53.67 49.55 55.36 57.74 56.14 55.16 Payable days 71.94 66.81 61.95 56.43 51.50 43.27 52.71 30.79 20.33 42.71 Cash Conversion Cycle 74.95 73.68 63.66 62.01 63.53 71.42 71.15 92.03 104.31 99.11 Total Debt/Equity 0.45 0.42 0.43 0.24 0.18 0.20 0.29 0.30 0.28 0.21 Interest Cover 0.55 3.06 15.83 9.17 11.59 4.84 3.21 4.14 17.03 15.84

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 06 Jun 05
Book Value (Rs.) 71.69 73.25 70.68 62.56 56.30 49.61 44.94 22.28 19.62 ROA -0.24% 3.42% 7.22% 9.15% 10.52% 8.17% 8.53% 10.57% 8.79% ROE -0.43% 6.21% 12.55% 14.96% 16.97% 13.32% 13.98% 16.96% 14.40% ROCE 1.17% 7.62% 11.80% 16.72% 20.63% 16.84% 18.33% 21.31% 18.06% Fixed Asset Turnover 1.06 1.26 1.55 1.69 1.69 1.61 2.10 2.00 2.08 Receivable days 76.39 74.23 67.31 62.31 61.67 64.94 59.83 106.60 125.29 Inventory Days 71.01 66.40 58.84 57.17 54.49 49.80 36.61 44.48 50.93 Payable days 71.91 66.57 61.79 56.58 52.08 43.51 39.89 77.53 93.34 Cash Conversion Cycle 75.49 74.06 64.37 62.91 64.09 71.24 56.55 73.55 82.88 Total Debt/Equity 0.45 0.42 0.43 0.24 0.19 0.20 0.29 0.18 0.29 Interest Cover 0.55 3.06 15.64 8.98 11.35 4.82 3.22 8.41 10.77

Top Investors:

reliance capital trustee co ltd a/c nippon india

dsp top 100 equity fund

icici prudential pharma healthcare and diaganostic

mangeshi investments private limited

Annual Reports:

News Update:

Indoco Remedies gets USFDA’s nod for Apixaban Tablets
14th Sep 2020, 10:34 AM

It is used for patients with health problems caused by a blood clot
Read More
Indoco Remedies - Quarterly Results
11th Aug 2020, 12:05 PM

Read More
Indoco Remedies gets USFDA’s nod for Olanzapine Tablets
6th Aug 2020, 10:01 AM

Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback